1.0 jean-françois delfraissy intro
•Download as PPT, PDF•
1 like•388 views
Infectious diseases account for a significant portion of global mortality, particularly in developing countries. New pathogens are emerging and spreading rapidly, while multidrug-resistant pathogens are a growing problem. A multidisciplinary approach is needed to address infectious disease challenges. This document outlines the agenda for the 3rd International Research Meeting on microbiology and infectious diseases, highlighting France's major research institutions in this area and the scientific sessions to be covered.
Report
Share
Report
Share
Recommended
Bokk+final+du+10+juin+2011
Professeur Jean-François Delfraissy, ITMO IMMI, Paris
1. New mechanisms/paradigms
Moderators: François Loïc Cosset, Lyon and Olivier Schwartz,
Institut Pasteur Paris
Speakers: Philippe Sansonnetti, Institut Pasteur Paris :
From bugs and men to treatments and vaccines
Eric Oswald, Toulouse: Escherichia coli: the enemy within
Stéphanie Blandin, Strasbourg: Towards new approaches
to control malaria gambiae
Marc Lecuit, Institut Pasteur Paris: Microbes and host barriers
Ivo Gomperts
Infectious disease p1
This document summarizes several viral infections including measles, mumps, poliovirus, viral hemorrhagic fevers, herpes viruses, cytomegalovirus, varicella-zoster virus, hepatitis B virus, Epstein-Barr virus, and human papillomaviruses. It describes the viruses that cause each infection, how they are transmitted, the path they take in the body, clinical manifestations, morphologic findings, and potential complications. Chronic infections like herpes viruses and hepatitis B are able to evade the immune system and cause long-term infections while others like measles and mumps typically cause acute, transient infections.
Infectious Dz Lecture #1
This document provides an overview of infectious diseases and the immune system. It discusses the innate and adaptive immune response, key components of innate immunity like soluble and cellular factors, and adaptive responses involving B cells and T cells. It also summarizes various clinical pathogens including bacteria, viruses, fungi and parasites; diagnostic approaches; antimicrobial mechanisms of action; and important antimicrobial drug classes.
Tuberculosis among patients Infected with Human Immunodeficiency Virus
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
final poster
Peter Doherty was born in Brisbane, Australia and attended school there. He joined the John Curtin School of Medical Research in 1972 where he met Rolf Zinkernagel. They discovered that T-cells in mice infected with lymphocytic virus (LCMV) were able to attack and kill cells infected with the virus. This began their research collaboration. Doherty and Zinkernagel found that T-cells must recognize both the viral antigen and the major histocompatibility complex (MHC) molecule on the infected cell surface to initiate the killing of that cell. This discovery of MHC restriction was seminal in understanding cell-mediated immunity.
Vnu – hanoi university of sciences
This document summarizes information about Ebola virus. It describes how Peter Piot received a thermos of blood from a nun who had fallen ill with a mysterious disease in Congo in 1976. Piot and his colleagues studied the epidemic and found clues about how the virus spreads. The recent 2014 outbreak in West Africa caused over 6000 deaths. The document provides details on the structure and life cycle of Ebola virus, how it is transmitted from animals to humans and between humans, symptoms of the disease, and challenges in developing treatments.
Tuberculosis
This document provides an overview of tuberculosis (TB), including its causes, types, diagnosis, and treatment. Some key points:
- TB is caused by the bacterium Mycobacterium tuberculosis and kills over 1.6 million people worldwide each year. It is a major global health problem, especially in developing countries.
- Pulmonary TB affects the lungs and is the most common type. Extra-pulmonary TB can affect other organs. Diagnosis involves sputum smear, culture, chest x-ray, and tuberculin skin testing.
- Treatment requires a multi-drug regimen over several months to cure the infection and prevent drug resistance. Directly observed therapy is recommended to ensure patient adherence
Recommended
Bokk+final+du+10+juin+2011
Professeur Jean-François Delfraissy, ITMO IMMI, Paris
1. New mechanisms/paradigms
Moderators: François Loïc Cosset, Lyon and Olivier Schwartz,
Institut Pasteur Paris
Speakers: Philippe Sansonnetti, Institut Pasteur Paris :
From bugs and men to treatments and vaccines
Eric Oswald, Toulouse: Escherichia coli: the enemy within
Stéphanie Blandin, Strasbourg: Towards new approaches
to control malaria gambiae
Marc Lecuit, Institut Pasteur Paris: Microbes and host barriers
Ivo Gomperts
Infectious disease p1
This document summarizes several viral infections including measles, mumps, poliovirus, viral hemorrhagic fevers, herpes viruses, cytomegalovirus, varicella-zoster virus, hepatitis B virus, Epstein-Barr virus, and human papillomaviruses. It describes the viruses that cause each infection, how they are transmitted, the path they take in the body, clinical manifestations, morphologic findings, and potential complications. Chronic infections like herpes viruses and hepatitis B are able to evade the immune system and cause long-term infections while others like measles and mumps typically cause acute, transient infections.
Infectious Dz Lecture #1
This document provides an overview of infectious diseases and the immune system. It discusses the innate and adaptive immune response, key components of innate immunity like soluble and cellular factors, and adaptive responses involving B cells and T cells. It also summarizes various clinical pathogens including bacteria, viruses, fungi and parasites; diagnostic approaches; antimicrobial mechanisms of action; and important antimicrobial drug classes.
Tuberculosis among patients Infected with Human Immunodeficiency Virus
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
final poster
Peter Doherty was born in Brisbane, Australia and attended school there. He joined the John Curtin School of Medical Research in 1972 where he met Rolf Zinkernagel. They discovered that T-cells in mice infected with lymphocytic virus (LCMV) were able to attack and kill cells infected with the virus. This began their research collaboration. Doherty and Zinkernagel found that T-cells must recognize both the viral antigen and the major histocompatibility complex (MHC) molecule on the infected cell surface to initiate the killing of that cell. This discovery of MHC restriction was seminal in understanding cell-mediated immunity.
Vnu – hanoi university of sciences
This document summarizes information about Ebola virus. It describes how Peter Piot received a thermos of blood from a nun who had fallen ill with a mysterious disease in Congo in 1976. Piot and his colleagues studied the epidemic and found clues about how the virus spreads. The recent 2014 outbreak in West Africa caused over 6000 deaths. The document provides details on the structure and life cycle of Ebola virus, how it is transmitted from animals to humans and between humans, symptoms of the disease, and challenges in developing treatments.
Tuberculosis
This document provides an overview of tuberculosis (TB), including its causes, types, diagnosis, and treatment. Some key points:
- TB is caused by the bacterium Mycobacterium tuberculosis and kills over 1.6 million people worldwide each year. It is a major global health problem, especially in developing countries.
- Pulmonary TB affects the lungs and is the most common type. Extra-pulmonary TB can affect other organs. Diagnosis involves sputum smear, culture, chest x-ray, and tuberculin skin testing.
- Treatment requires a multi-drug regimen over several months to cure the infection and prevent drug resistance. Directly observed therapy is recommended to ensure patient adherence
Tuberculosis
tuberculosis : definition, epidemology, transmission of tuberculosis, stages of tuberculosis, types of tuberculosis,etiology, pathogenesis, pathophysiology, clinical presentations, diagnosis, treatment of tuberculosis, treatment of tuberculosis in breastfeeding, pregnancy, HIV/AIDS, oral contraceptives, renal failure, liver failure conditions and multi-drug resistance tuberculosis : types , diagnosis, and treatment
COVID-19 AMONG ELDERLY PATIENTS
The document discusses COVID-19 among elderly patients in Brazil. It first describes how SARS-CoV-2 infects host cells through the spike protein and hijacks the cell's machinery to replicate itself. It then notes that the first COVID-19 cases occurred in Wuhan in December 2019 and have since spread globally. Most patients treated in hospitals for COVID-19 were over 70 years old, and among deceased patients about 50% were over 83. The virus' symptoms in elderly patients did not always present as the typical fever, cough and dyspnea and were sometimes confused with other age-related illnesses. However, persistent diarrhea was found to be linked to COVID-19 infection in some cases.
Drugs for nosocomial infection
This document discusses nosocomial (hospital-acquired) infections. It begins by defining nosocomial infections and providing statistics on their incidence, particularly in ICUs. It then covers the pathogens involved, including bacteria like Staphylococcus aureus and viruses. Risk factors for infection and methods of transmission are examined. The document outlines prevention strategies and therapeutic guidelines for treating common infections. Throughout, it provides historical context and milestones in the understanding and management of nosocomial infections.
12 course and_forms_of_infection_-_i_2_
This document discusses various topics related to the course and forms of infection. It covers incubation periods for different diseases, the typical progression of infectious diseases from prodromal symptoms to convalescence. It also discusses types of infections such as latent, persistent, opportunistic, and nosocomial infections. The outcome of infections depends on factors related to the microorganism and the host such as virulence, immunity, and response. Complete recovery, recovery with sequelae, persistent infection, and death are some potential outcomes.
Tuberculosis
Tuberculosis is a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis, which most commonly affects the lungs. It is one of the top 10 causes of death worldwide. The disease is transmitted through the air when people who are sick with TB expel bacteria into the air, for example by coughing. Common symptoms include cough with sputum and blood at times, fever, night sweats, and weight loss. Diagnosis involves tests such as chest X-rays, sputum smear microscopy, and culture. Treatment involves a combination of antibiotics over a period of 6-9 months. The Revised National Tuberculosis Control Programme aims to reduce mortality and transmission of TB in India through improved case detection and
Ebola
Lecture By:
DR.SATTI MOHAMMED SALEH
MEEQAT HOSPITAL MEDICAL DIRECOR
INFECTION CONTROL DIRECTOR
CBAHI SIT MEMBER
Tuberculosis
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacteria that generally affects the lungs. There were an estimated 8.6 million new cases of tuberculosis globally in 2012, with the highest numbers occurring in Asia and Africa. The global incidence of tuberculosis has been slowly declining since 2002 due to control efforts. Tuberculosis can be either latent, where the immune system keeps the bacteria from spreading but it remains alive in the body, or active, where the bacteria multiply and cause illness.
Tuberculosis
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacteria that generally affects the lungs. There were an estimated 8.6 million new cases of tuberculosis globally in 2012, with the highest numbers occurring in Asia and Africa. The global incidence of tuberculosis has been slowly declining since 2002 due to control efforts. Tuberculosis can be either latent, where the immune system keeps the bacteria from spreading but it remains alive in the body, or active, where the bacteria multiply and cause illness.
Mycobacterium Tuberculosis TB
This document provides an overview of tuberculosis (TB) including its definition, causative agent, risk factors, epidemiology, pathophysiology, diagnosis, treatment and management, and desired outcomes. TB is caused by the bacterium Mycobacterium tuberculosis and produces latent, silent infections that can develop into active, progressive disease. It is diagnosed through tests such as tuberculin skin tests, sputum smears, chest radiography, and nucleic acid amplification. Treatment involves a multi-drug regimen over a period of 6-9 months with first-line antibiotics like isoniazid, rifampin, pyrazinamide, and ethambutol. Management also includes measures like proper nutrition, not smoking/dr
Tuberclosis
1) TB is caused by Mycobacterium tuberculosis and is one of the top infectious disease killers.
2) It is transmitted through the air and one-third of the world's population is infected with latent TB.
3) Diagnosis involves sputum smear microscopy, culture, tuberculin skin test, chest x-ray and PCR. Treatment requires a minimum of 6 months of multiple antibiotic drugs.
Tuberculosis
Tuberculosis is a contagious infection caused by the bacterium Mycobacterium tuberculosis, which usually affects the lungs. It spreads through the air when people with the active respiratory disease cough, sneeze or speak. Common symptoms include weakness, weight loss, fever, night sweats and cough. Diagnosis involves a medical history, physical exam, tuberculin skin test or blood test, chest x-ray and microbiological tests. Treatment requires multiple antibiotics taken for several months and directly observed therapy is recommended to prevent drug resistance and ensure adherence.
Pulmonary Tuberculosis
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
uts-vol1
UCSD undergraduate researchers are studying various ecosystems and their components in order to better understand their functioning and identify factors crucial for preservation. Studies described include examining the role of the Wnt signaling pathway in mammary gland and stem cell development, investigating how the antibiotic salinomycin affects cancer stem cells, and exploring the foraging behavior of bees and life histories of cacti. The goal is to gain insights that can inform effective conservation strategies to protect interdependent living things and environments.
Jai cmb
This document provides an overview of the life cycle and pathogenesis of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). It discusses how M. tuberculosis is transmitted via airborne droplets, establishes a latent infection that may later develop into active TB disease, and can infect multiple body sites. The document also covers drug-resistant forms of TB and describes the diagnosis, treatment, and prevention of the disease.
Tuberculosis
Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis.
TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. A person needs to inhale only a few of these germs to become infected.
M. Tuberculosis and immune responses
This document outlines a presentation on tuberculosis (TB) given by M. Barabadi and S. Keshavarz Shahbaz at Tehran University of Medical Sciences. It discusses the history, epidemiology, bacteriology, clinical features, experimental models, and immune response to TB. The summary focuses on key points:
1. Mycobacterium tuberculosis is the pathogen that causes TB. It is a slow-growing, facultative intracellular, acid-fast bacillus.
2. TB can be active or latent. Active TB causes symptoms while latent TB involves infection without symptoms. Most infected individuals develop latent TB which has a 5-10% risk of progressing to active disease.
3. The
Tuberculosis
Tuberculosis, or TB, is caused by bacteria that usually affect the lungs. It can be spread through the air when someone with active TB coughs or sneezes. There are two types of TB infection - latent TB, where the bacteria remain inactive in the body, and active TB, where the bacteria are causing symptoms and can be transmitted. To prevent the spread of TB, it is important to avoid exposure to those with active infections, get tested if exposed, and begin treatment right away if diagnosed with latent TB.
pulmonary Tuberculosis
Tuberculosis has affected humans for thousands of years and evidence of it has been found in remains from ancient Egypt and other early civilizations. While tuberculosis was identified as a single disease in the 1820s, it was not until the mid-19th century that it became understood as being caused by the bacterium Mycobacterium tuberculosis. Throughout history, tuberculosis was a widespread and usually fatal disease until the development of antibiotics in the 20th century provided effective treatments.
Tuberclosis pharmacotherapy
Tuberculosis (TB) remains a major global health problem. The document discusses TB, including its epidemiology in Pakistan. It describes the etiology, signs and symptoms, diagnosis, and treatment of active TB. TB is caused by the bacterium Mycobacterium tuberculosis. Diagnosis involves sputum smear, culture and chest x-ray. Treatment requires a multi-drug regimen over 6-9 months using drugs like isoniazid and rifampin under direct observation. Drug resistant TB poses a challenge to effective treatment.
05 rencontres biomédicale LIR Dusko Ehrlich
1. The MetaHIT project analyzed the gut microbiomes of over 100 Europeans and found a 3.3 million gene catalog, 150 times larger than the human genome. They identified bacterial genes associated with obesity, Crohn's disease, and ulcerative colitis.
2. The MetaHIT Consortium, funded by the European Commission, involves 12 European institutions studying the relationship between gut microbes and human health and disease. They are developing tools to profile the microbiome and searching for associations between microbes and diseases like IBD and obesity.
3. Preliminary studies found certain bacterial species that can discriminate between healthy and diseased groups like obese individuals and those with Crohn's or ulcerative colitis. Future work may
14 rencontres biomédicale LIR Philippe Menasché
The document discusses stem cell research in France for cardiovascular diseases. It outlines France's long experience in cell therapy and efforts to streamline clinical trials. It describes research on embryonic stem cells and cell transplantation trials for heart failure. It emphasizes lessons from early experiences, such as tailoring cell choice to indications and optimizing cell engraftment. Finally, it discusses opportunities for induced pluripotent stem cell research based on existing ESC expertise in France.
3.1 francois dabis
The document discusses French-based international research networks that focus on tackling infectious diseases, which cause 2/3 of deaths in children under 5 years old. It outlines 4 networks that are active in developing countries and focus on areas like respiratory infections, encephalitis, HIV/AIDS, hepatitis, zoonosis, dengue, and malaria. Their research tools include microorganism culture, biobanks, databanks, surveillance cohorts, and entomology. It then discusses challenges of the HIV/AIDS pandemic and the need to increase prevention and care research, and describes experiences lowering mother-to-child HIV transmission rates in various countries. It calls for more public and private investments from basic to translational research using existing
More Related Content
What's hot
Tuberculosis
tuberculosis : definition, epidemology, transmission of tuberculosis, stages of tuberculosis, types of tuberculosis,etiology, pathogenesis, pathophysiology, clinical presentations, diagnosis, treatment of tuberculosis, treatment of tuberculosis in breastfeeding, pregnancy, HIV/AIDS, oral contraceptives, renal failure, liver failure conditions and multi-drug resistance tuberculosis : types , diagnosis, and treatment
COVID-19 AMONG ELDERLY PATIENTS
The document discusses COVID-19 among elderly patients in Brazil. It first describes how SARS-CoV-2 infects host cells through the spike protein and hijacks the cell's machinery to replicate itself. It then notes that the first COVID-19 cases occurred in Wuhan in December 2019 and have since spread globally. Most patients treated in hospitals for COVID-19 were over 70 years old, and among deceased patients about 50% were over 83. The virus' symptoms in elderly patients did not always present as the typical fever, cough and dyspnea and were sometimes confused with other age-related illnesses. However, persistent diarrhea was found to be linked to COVID-19 infection in some cases.
Drugs for nosocomial infection
This document discusses nosocomial (hospital-acquired) infections. It begins by defining nosocomial infections and providing statistics on their incidence, particularly in ICUs. It then covers the pathogens involved, including bacteria like Staphylococcus aureus and viruses. Risk factors for infection and methods of transmission are examined. The document outlines prevention strategies and therapeutic guidelines for treating common infections. Throughout, it provides historical context and milestones in the understanding and management of nosocomial infections.
12 course and_forms_of_infection_-_i_2_
This document discusses various topics related to the course and forms of infection. It covers incubation periods for different diseases, the typical progression of infectious diseases from prodromal symptoms to convalescence. It also discusses types of infections such as latent, persistent, opportunistic, and nosocomial infections. The outcome of infections depends on factors related to the microorganism and the host such as virulence, immunity, and response. Complete recovery, recovery with sequelae, persistent infection, and death are some potential outcomes.
Tuberculosis
Tuberculosis is a chronic infectious disease caused by the bacterium Mycobacterium tuberculosis, which most commonly affects the lungs. It is one of the top 10 causes of death worldwide. The disease is transmitted through the air when people who are sick with TB expel bacteria into the air, for example by coughing. Common symptoms include cough with sputum and blood at times, fever, night sweats, and weight loss. Diagnosis involves tests such as chest X-rays, sputum smear microscopy, and culture. Treatment involves a combination of antibiotics over a period of 6-9 months. The Revised National Tuberculosis Control Programme aims to reduce mortality and transmission of TB in India through improved case detection and
Ebola
Lecture By:
DR.SATTI MOHAMMED SALEH
MEEQAT HOSPITAL MEDICAL DIRECOR
INFECTION CONTROL DIRECTOR
CBAHI SIT MEMBER
Tuberculosis
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacteria that generally affects the lungs. There were an estimated 8.6 million new cases of tuberculosis globally in 2012, with the highest numbers occurring in Asia and Africa. The global incidence of tuberculosis has been slowly declining since 2002 due to control efforts. Tuberculosis can be either latent, where the immune system keeps the bacteria from spreading but it remains alive in the body, or active, where the bacteria multiply and cause illness.
Tuberculosis
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis bacteria that generally affects the lungs. There were an estimated 8.6 million new cases of tuberculosis globally in 2012, with the highest numbers occurring in Asia and Africa. The global incidence of tuberculosis has been slowly declining since 2002 due to control efforts. Tuberculosis can be either latent, where the immune system keeps the bacteria from spreading but it remains alive in the body, or active, where the bacteria multiply and cause illness.
Mycobacterium Tuberculosis TB
This document provides an overview of tuberculosis (TB) including its definition, causative agent, risk factors, epidemiology, pathophysiology, diagnosis, treatment and management, and desired outcomes. TB is caused by the bacterium Mycobacterium tuberculosis and produces latent, silent infections that can develop into active, progressive disease. It is diagnosed through tests such as tuberculin skin tests, sputum smears, chest radiography, and nucleic acid amplification. Treatment involves a multi-drug regimen over a period of 6-9 months with first-line antibiotics like isoniazid, rifampin, pyrazinamide, and ethambutol. Management also includes measures like proper nutrition, not smoking/dr
Tuberclosis
1) TB is caused by Mycobacterium tuberculosis and is one of the top infectious disease killers.
2) It is transmitted through the air and one-third of the world's population is infected with latent TB.
3) Diagnosis involves sputum smear microscopy, culture, tuberculin skin test, chest x-ray and PCR. Treatment requires a minimum of 6 months of multiple antibiotic drugs.
Tuberculosis
Tuberculosis is a contagious infection caused by the bacterium Mycobacterium tuberculosis, which usually affects the lungs. It spreads through the air when people with the active respiratory disease cough, sneeze or speak. Common symptoms include weakness, weight loss, fever, night sweats and cough. Diagnosis involves a medical history, physical exam, tuberculin skin test or blood test, chest x-ray and microbiological tests. Treatment requires multiple antibiotics taken for several months and directly observed therapy is recommended to prevent drug resistance and ensure adherence.
Pulmonary Tuberculosis
These lecture notes were prepared by Dr. Hamdi Turkey- Pulmonologist- Department of internal medicine - Taiz university
Do Not Forget To Visit Our Pages On Facebook on the following Links:
https://www.facebook.com/groups/569435236444761/
AND
https://www.facebook.com/groups/690331650977113/
uts-vol1
UCSD undergraduate researchers are studying various ecosystems and their components in order to better understand their functioning and identify factors crucial for preservation. Studies described include examining the role of the Wnt signaling pathway in mammary gland and stem cell development, investigating how the antibiotic salinomycin affects cancer stem cells, and exploring the foraging behavior of bees and life histories of cacti. The goal is to gain insights that can inform effective conservation strategies to protect interdependent living things and environments.
Jai cmb
This document provides an overview of the life cycle and pathogenesis of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). It discusses how M. tuberculosis is transmitted via airborne droplets, establishes a latent infection that may later develop into active TB disease, and can infect multiple body sites. The document also covers drug-resistant forms of TB and describes the diagnosis, treatment, and prevention of the disease.
Tuberculosis
Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis.
TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. A person needs to inhale only a few of these germs to become infected.
M. Tuberculosis and immune responses
This document outlines a presentation on tuberculosis (TB) given by M. Barabadi and S. Keshavarz Shahbaz at Tehran University of Medical Sciences. It discusses the history, epidemiology, bacteriology, clinical features, experimental models, and immune response to TB. The summary focuses on key points:
1. Mycobacterium tuberculosis is the pathogen that causes TB. It is a slow-growing, facultative intracellular, acid-fast bacillus.
2. TB can be active or latent. Active TB causes symptoms while latent TB involves infection without symptoms. Most infected individuals develop latent TB which has a 5-10% risk of progressing to active disease.
3. The
Tuberculosis
Tuberculosis, or TB, is caused by bacteria that usually affect the lungs. It can be spread through the air when someone with active TB coughs or sneezes. There are two types of TB infection - latent TB, where the bacteria remain inactive in the body, and active TB, where the bacteria are causing symptoms and can be transmitted. To prevent the spread of TB, it is important to avoid exposure to those with active infections, get tested if exposed, and begin treatment right away if diagnosed with latent TB.
pulmonary Tuberculosis
Tuberculosis has affected humans for thousands of years and evidence of it has been found in remains from ancient Egypt and other early civilizations. While tuberculosis was identified as a single disease in the 1820s, it was not until the mid-19th century that it became understood as being caused by the bacterium Mycobacterium tuberculosis. Throughout history, tuberculosis was a widespread and usually fatal disease until the development of antibiotics in the 20th century provided effective treatments.
Tuberclosis pharmacotherapy
Tuberculosis (TB) remains a major global health problem. The document discusses TB, including its epidemiology in Pakistan. It describes the etiology, signs and symptoms, diagnosis, and treatment of active TB. TB is caused by the bacterium Mycobacterium tuberculosis. Diagnosis involves sputum smear, culture and chest x-ray. Treatment requires a multi-drug regimen over 6-9 months using drugs like isoniazid and rifampin under direct observation. Drug resistant TB poses a challenge to effective treatment.
What's hot (19)
Viewers also liked
05 rencontres biomédicale LIR Dusko Ehrlich
1. The MetaHIT project analyzed the gut microbiomes of over 100 Europeans and found a 3.3 million gene catalog, 150 times larger than the human genome. They identified bacterial genes associated with obesity, Crohn's disease, and ulcerative colitis.
2. The MetaHIT Consortium, funded by the European Commission, involves 12 European institutions studying the relationship between gut microbes and human health and disease. They are developing tools to profile the microbiome and searching for associations between microbes and diseases like IBD and obesity.
3. Preliminary studies found certain bacterial species that can discriminate between healthy and diseased groups like obese individuals and those with Crohn's or ulcerative colitis. Future work may
14 rencontres biomédicale LIR Philippe Menasché
The document discusses stem cell research in France for cardiovascular diseases. It outlines France's long experience in cell therapy and efforts to streamline clinical trials. It describes research on embryonic stem cells and cell transplantation trials for heart failure. It emphasizes lessons from early experiences, such as tailoring cell choice to indications and optimizing cell engraftment. Finally, it discusses opportunities for induced pluripotent stem cell research based on existing ESC expertise in France.
3.1 francois dabis
The document discusses French-based international research networks that focus on tackling infectious diseases, which cause 2/3 of deaths in children under 5 years old. It outlines 4 networks that are active in developing countries and focus on areas like respiratory infections, encephalitis, HIV/AIDS, hepatitis, zoonosis, dengue, and malaria. Their research tools include microorganism culture, biobanks, databanks, surveillance cohorts, and entomology. It then discusses challenges of the HIV/AIDS pandemic and the need to increase prevention and care research, and describes experiences lowering mother-to-child HIV transmission rates in various countries. It calls for more public and private investments from basic to translational research using existing
13 rencontres biomédicale LIR Renato Monteiro
1) Glomerulonephritis (GN) is inflammation of the glomeruli in the kidneys that can be caused by conditions like IgA nephropathy and systemic lupus erythematosus. There are currently no specific treatments available.
2) The document describes research into developing therapeutic antibodies for treating renal inflammation and GN by targeting the IgA receptor CD89.
3) One such therapeutic antibody, a Fab fragment against CD89, has shown promise in suppressing renal inflammation and reducing renal fibrosis in mouse models of GN. This antibody may be a potential new anti-inflammatory treatment for severe nephritis.
Publication ph-aghion-croissance-et-sante
1) The document discusses the relationship between health and economic growth, drawing on both the Lucas and Nelson-Phelps approaches. It proposes a theoretical framework that encompasses both the level and accumulation of health as factors that can impact growth.
2) Empirically, using cross-country regressions and instruments from previous studies, the document finds that both the initial level and rate of improvement in life expectancy have a significantly positive impact on GDP growth.
3) Looking specifically at OECD countries, the document finds evidence that only reductions in mortality below age 40 (not overall mortality improvements) generate productivity gains that explain the positive health-growth relationship.
3.2 eric leroy
1. The document discusses Ebola virus as an emergent pathogen that infects humans and animals in Africa, with a mortality rate of around 80%.
2. It describes tracking the virus through field investigations of outbreaks and laboratory studies to understand its transmission from bats to great apes to humans, evolution, and pathogenesis.
3. It examines routes of human-to-human transmission and strategies to control outbreaks through prevention, as well as perspectives on developing vaccines and therapies and improving global disease surveillance.
Rir 10th june_2011_v2
The document summarizes the research of two teams within the Institut thématique Microbiologie et Maladies infectieuses laboratory on human genetics of infectious diseases. The teams, led by Laurent Abel and Jean-Laurent Casanova, work together to understand genetic susceptibility to both common and rare infections using complex and single-gene approaches. Abel's team has identified genes associated with susceptibility to leprosy, tuberculosis, hepatitis C virus and other infections. Casanova's team has revealed single-gene defects that cause severe vulnerability to illnesses like herpes encephalitis and mycobacterial diseases in children. Their research aims to further understand the genetic basis of infectious disease susceptibility and pathogenesis.
07 rencontres biomédicale LIR Bart Staels
This document discusses diabetes and cardiovascular disease risk factors and complications. It summarizes that obesity predisposes individuals to both diabetes and cardiovascular disease. It then outlines various circadian and molecular pathways involved in metabolic regulation and the potential role of nuclear receptors and transcription factors like Rev-erbα and RORα. Finally, it describes several European research consortia studying diabetes and cardiovascular disease, as well as the creation of the European Genomics Institute of Diabetes, which aims to conduct basic, clinical, and translational research towards developing new diabetes treatments through collaborations between academia and the pharmaceutical industry.
03 rencontres biomédicale LIR Xavier Jeunemaitre
This document discusses the genetics of cardiovascular diseases, from rare familial forms to more common diseases. It describes how studying rare Mendelian forms of hypertension and hypercholesterolemia led to the discovery of pathways involved in these diseases, such as the LDL receptor pathway and the WNK kinase family. Targets identified from rare diseases, such as PCSK9 and components of the renin-angiotensin system, are now targets for therapies for more common cardiovascular diseases. The document advocates that continued study of rare disease families can provide insights into pathways and potential new drug targets for widespread cardiovascular conditions.
10 rencontres biomédicale LIR Faiez Zannad
The document discusses how French clinical networks can accelerate the discovery of new treatments for cardiovascular and metabolic diseases. It describes the network of Clinical Investigation Centers in France and their resources like biobanks, databases, and cohorts. It provides examples of successes like discoveries of new medications and biomarkers. It discusses opportunities for industry-academic collaboration on multicenter clinical trials through an proposed European Drug Development Hub.
0.1 andr syrota
The document summarizes the goals and activities of Aviesan, the French Alliance for Life and Health Sciences. It aims to optimize scientific foresight, facilitate research clusters, and promote national projects. It represents major French research organizations and operates through 10 thematic institutes. It also maintains a catalog of 237 French health databases and supports several large research projects and infrastructures through funding from "Investments for the future", totaling billions of euros over 10 years.
2.6 didier raoult
This document summarizes the 3rd meeting of the international research group on infectious diseases and microbiology. The meeting discussed completing the gene repertoire of microorganisms by comparing genomes from environments, healthy humans, and patients to identify links to diseases. It was noted that current metagenomic studies have only identified 10-15% of organisms with ribosomes and 15-30% of known viruses. Tools discussed included using culture-introducing culturomics, genome sequencing and analysis. Specific results mentioned were related to giant viruses, the microbiota and obesity, causes of fever in Africa, and developing new culture media and vaccines.
08 rencontres biomédicale LIR Richard Moreau
The document discusses non-alcoholic fatty liver disease (NAFLD) and obesity-related liver inflammation and cancer. It notes that in humans, obesity can lead to NAFLD, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. In mice, obesity promotes liver inflammation and cancer by enhancing pro-inflammatory cytokines. It identifies several unknown areas regarding genes and biomarkers for NAFLD progression and cancer development. The document proposes investigating the metagenome, intra-hepatic cytokine signaling, and performing genome-wide association studies to identify targets for new drug molecules, and evaluating these molecules in clinical trials using available French cohorts, biobanks
11 rencontres biomédicale lLIR Tabassonme Simon
1) The FAST-MI network in France characterized over 3,600 acute myocardial infarction patients between 2005-2010, collecting DNA samples, serum, and over 400 clinical variables to study the pathophysiology and pharmacogenetics of cardiovascular disease.
2) Analysis of the FAST-MI data identified genetic variants that influence drug absorption and metabolism, and found associations between serum levels of secretory phospholipase A2, its genetic variants, and cardiovascular outcomes after one year.
3) The FAST-MI network continues ongoing studies, has published numerous papers, and aims to further understanding of biomarkers and genetic influences on diabetes and cardiovascular drug response.
The relationship between_health_and_growth
This paper revisits the relationship between health and growth in light of modern endogenous growth theory. We propose an unified framework that encompasses the growth effects of both, the accumulation and the level of health. Based on cross-country regressions where we instrument for both variables, we find that a higher initial level and a higher rate of improvement in life expectancy, both have a significantly positive impact on per capita GDP growth.
2.5 behazine combadiere
This document discusses skin targeting for vaccine efficacy. It notes that targeting different antigen-presenting cells (APCs) in the skin can dictate the intensity, quality, and localization of the immune response. Specifically, targeting Langerhans cells in the hair follicles can favor CD8 T cell responses and mucosal immunity, though may not induce strong IgG responses. It provides evidence from a phase I clinical trial that influenza vaccination via the transcutaneous route targeting hair follicle Langerhans cells induced better CD8 responses than intramuscular vaccination. The document advocates for more "tailor-cut" immunization strategies targeting specific APCs in the skin or other sites to optimize vaccine efficacy against various infectious diseases.
Viewers also liked (16)
Similar to 1.0 jean-françois delfraissy intro
Surveillance of emerging diseases and networks.
This document discusses disease surveillance networks and provides examples. It begins by defining key concepts like surveillance, emerging diseases, and networks. It then provides examples of successful surveillance networks, including SISEA/Pasteur in Southeast Asia, the Mekong Basin Disease Surveillance network, and tuberculosis surveillance. These networks improved disease detection and response through established nodes, standardized reporting procedures, and capacity building. The document concludes that interconnected surveillance networks can enhance sensitivity and specificity of disease detection compared to isolated efforts.
The future of the emergency room | Jean-Louis Vincent at TBS23
This document discusses the future of emergency medicine and intensive care. It suggests that emergency departments will see both smaller and larger patient populations as telemedicine and home care become more prevalent, allowing efficient comprehensive management. Specialists, labs, imaging, and AI will play larger roles. Triage and disposition may be aided by AI, and the roles of ER, ICU, and specialists will evolve in an integrated hospital network supported by telemedicine. Data standardization, large databases, and AI/machine learning can help provide personalized care and evaluate new therapies.
tuberculosis-150808111627-lva1-app6891.pdf
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis that mainly affects the lungs. It can spread through droplets in the air from coughing or sneezing. Symptoms include coughing, chest pain, and fatigue. Diagnosis involves sputum tests, chest x-rays, and tuberculin skin tests. Treatment involves a combination of antibiotics taken for 6-9 months. Preventive measures include BCG vaccination, isolation, and proper ventilation. Drug-resistant TB strains like MDR-TB and XDR-TB require longer and more toxic treatment regimens. HIV co-infection increases the risk of active TB disease.
Tuberculosis
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis that mainly affects the lungs. It can spread through droplets in the air from coughing or sneezing. Symptoms include coughing, chest pain, and fatigue. Diagnosis involves sputum tests, chest x-rays, and tuberculin skin tests. Treatment involves a combination of antibiotics taken for 6-9 months. Preventive measures include BCG vaccination, isolation, and proper ventilation. Drug-resistant TB strains like MDR-TB and XDR-TB require longer and more toxic treatment regimens. HIV co-infection increases the risk of active TB disease.
tuberculosis ram. nepal civil service hosp
Tuberculosis is an infectious disease caused mainly by Mycobacterium tuberculosis that typically affects the lungs. It can be spread through droplets from the throat and lungs of people with the active respiratory disease. Tuberculosis can also affect other parts of the body in its extra pulmonary form. Diagnosis involves microscopic examination of sputum samples, culture tests and radiography. Treatment requires a multi-drug regimen over a period of 6-9 months. Preventive measures include BCG vaccination, isolation of active cases, and directly observed treatment.
chapter 81 - Zoonotic infections.pptx
The document discusses zoonotic infections transmitted from animals to humans. It provides details on plague caused by Yersinia pestis, including epidemiology, clinical types, diagnosis and treatment. It also discusses tularemia caused by Francisella tularensis and bite wound infections. Common zoonotic infections are transmitted via bites or contact with infected animals and vectors like fleas and ticks. Proper control of reservoirs and vectors is important for prevention.
Black Death and plague: a new understanding
OMICS Group is an organization committed to making scientific research openly accessible. It hosts over 400 peer-reviewed open access journals and organizes over 300 international conferences annually. The organization has over 3 million readers for its journals. It aims to serve the scientific community by ensuring a rapid peer review process from its large editorial board of over 30,000 reviewers. OMICS Group also partners with over 1000 international societies to make healthcare information openly accessible. It welcomes high-quality research submissions and follows a peer review process to maintain journal excellence.
Nosocomial infections prevention
This document summarizes nosocomial infections and their control. It defines nosocomial infections as those acquired in a hospital by a patient admitted for another reason. The most common types are urinary tract infections, surgical site infections, and pneumonia. Transmission occurs via contact, droplets, and contaminated equipment. Proper hand hygiene, isolation, sterilization of equipment, and environmental cleaning are effective prevention strategies.
Hiv 201111111
HIV/AIDS remains a major global epidemic, infecting over 59 million people worldwide since the 1980s and causing over 20 million deaths. Developing countries account for most new HIV infections, with sub-Saharan Africa the hardest hit region. While there is no cure for HIV, treatment using antiretroviral drugs can control the virus and prevent transmission. Developing an effective HIV vaccine remains challenging due to the virus's ability to mutate and evade the immune system.
Epidemiological method of investigation. Epidemic Diagnosis.
This document discusses epidemiological methods for investigating and controlling infectious diseases, including observation, inspection, examination, and analysis of morbidity. It describes several historic pandemics such as the Plague of Justinian, the Black Death, and the 1918 influenza pandemic. Prevention and control measures outlined include improving public health, medical interventions, health education, and preventing disease importation. Specific measures discussed are prophylactic vaccination, isolation of infectious individuals, disrupting transmission through sanitation and disinfection, quarantine, and increasing population resistance.
All cause mortality in treated hiv-infected
This study analyzed data from 80,642 HIV-infected adults in European cohorts to compare mortality rates to the general population. The overall mortality rate was 1.2/100 person-years, 4.2 times higher than the general population. Among those with a CD4 count over 500/mm3, the mortality rate was similar to the general population for non-injection drug using men and women after 3 years. Mortality rates remained elevated for injection drug users, though decreased with longer durations of high CD4 counts. A prior AIDS diagnosis was associated with higher mortality, underlining the importance of early HIV diagnosis.
Hiv 2011
The document summarizes key information about HIV/AIDS, including:
1. HIV has infected 59 million people worldwide, with 20 million deaths. Developing countries account for 64% of cases and 2/3 of new infections.
2. Common early symptoms of HIV infection include fever, fatigue, rash, headache, lymphadenopathy, and gastrointestinal issues.
3. HIV is transmitted through unprotected sex, blood transfusions, needle sharing, and from mother to child during pregnancy, birth, or breastfeeding.
4. While there is no cure for HIV, treatment with antiretroviral drugs can control the virus and prevent transmission.
Toshiba's VISIONS Magazine - issue 25
VISIONS magazine is a publication of Toshiba Medical Systems Europe (Toshiba), and is offered free of charge to medical and health professionals. The magazine is published twice a year but is also available as an online portal. News items and articles are announced, pre-publication, via social media in dedicated groups. Toshiba stores data of readers and users, as far as known, of the online VISIONS portal. This data is used to send out the magazine and inform about new developments in the clinical market. Users can customize their preferences or opt-out in the online VISIONS profile at www.toshiba-medical.eu/visions. ©2015 by Toshiba Medical Systems Europe. All rights reserved
Safety measures and infection control
Safety measures and infection control is a good topic for safe practice in health sector and therefore to medical laboratory too.
Institut Pasteur: An International Partner To Implement One Health Maria VA...
Institut Pasteur: An International Partner To Implement One Health Maria VA...Global Risk Forum GRFDavos
The Institut Pasteur has a long history of implementing a One Health approach to address emerging infectious diseases. It has worked jointly with animal and human health sectors on diseases such as rabies, H5N1, and MERS-CoV through activities like field investigations, laboratory training, and vaccine development. While One Health approaches have been adopted in policies, local implementation remains a challenge due to issues like limited resources, sectoral barriers, and communication difficulties. The Institut Pasteur aims to strengthen One Health by expanding multisectoral collaborations during outbreak responses and translating findings into improved public health protocols.Relations between pathogens, hosts and environment
Presentation of the EFSA's second scientific conference, held on 14-16 October 2015 in Milan, Italy.
DRIVERS FOR EMERGING ISSUES IN ANIMAL AND PLANT HEALTH
Infection control-core-competencies
Elaborating and implementing an infection control and hospital hygiene programme
Area 2. Quality improvement Implementing quality improvement initiatives
Area 3. Surveillance and investigation of healthcare-associated infections Surveillance and investigation
Area 4. Infection control activities Implementing infection control activities
Table A2. Areas, domains and competencies in infection control and hospital hygiene for junior and senior
specialists (introductory and expert levels)
Area 1. Programme management
Domain: Elaborating and implementing an infection control and hospital hygiene programme
Introductory level (junior specialist)
1.1 Describe the basic principles of infection control and hospital hygiene programmes
1.2
20180929 emerging & reemerging infections
This document discusses emerging and re-emerging infectious diseases. It begins by defining emerging infectious diseases as diseases whose incidence in humans has increased in recent times or threatens to increase. Re-emerging infectious diseases are those that were previously under control but are now increasing again. The document then discusses the classification of these diseases by the National Institute of Allergy and Infectious Diseases. It provides historical examples and details recent disease outbreaks in India like plague, diphtheria, leptospirosis, Nipah virus, and Chikungunya fever. It concludes by examining the factors that contribute to the emergence and reemergence of infectious diseases.
asepsis-in-dental-office-2247-2452-1-112.pdf
This document discusses cross-contamination risks in dental offices and proposes a solution called Aseptoflux. It notes that dental offices are places where infections can easily spread between patients and staff. Waiting rooms in particular pose risks as patients bring in germs on their bodies and shoes. Procedures like coughing and sneezing can spread pathogens through small droplets. The document then introduces Aseptoflux, an ultrasonic turbine that purifies the air by atomizing and returning it as a disinfecting spray, reducing cross-contamination risks over time with daily use. It discusses testing this system against other air purification methods, finding it significantly reduced bacterial colonies in dental facilities.
The Black death - a re-emerging infectious disease
Key question:
Could the plague ever re-emerge on a similar level in the twenty-first century?
Due to the potential seriousness of the disease this is a subject worthy of epidemiological consideration and research.
Similar to 1.0 jean-françois delfraissy intro (20)
The future of the emergency room | Jean-Louis Vincent at TBS23
The future of the emergency room | Jean-Louis Vincent at TBS23
Epidemiological method of investigation. Epidemic Diagnosis.
Epidemiological method of investigation. Epidemic Diagnosis.
Institut Pasteur: An International Partner To Implement One Health Maria VA...
Institut Pasteur: An International Partner To Implement One Health Maria VA...
Relations between pathogens, hosts and environment
Relations between pathogens, hosts and environment
The Black death - a re-emerging infectious disease
The Black death - a re-emerging infectious disease
More from Association LIR
Policies for conflicts_of_interest_lir_2011
In its role of think tank and within the framework of the “Assises du Médicament”, the LIR considered useful to make realize by the researchers of the ESSEC an international study on the policies of management of conflicts of interests.
Four reglementations were studied : United States, Great Britain, Germany and Sweden.
Observatoire bipe presentation_presse
Travaux LIR-BIPE présentés à la Presse le 24 septembre 2009 sur
Le Marché du Médicament remboursable (S1-2009) et la Consommation de médicaments en France
Impact sur la_longevite_et_croissance_economique
Les déficits cumulés de notre système d’assurance maladie, le vieillissement de notre population, l’augmentation de son espérance de vie, et l’augmentation des coûts associés à l’apparition de nouveaux équipements, posent avec acuité le problème du financement des dépenses de santé.
Si différentes réformes ont été introduites au cours des dernières années pour stabiliser nos dépenses de santé, les effets potentiels sur le secteur de la santé, l’innovation dans les industries et la croissance, ont trop rarement fait l’objet d’analyses approfondies.
Etude enjeux-vieillissement
Maladie d’Alzheimer, accident vasculaire cérébral, arthrose... Autant de pathologies que chacun d’entre nous connaît, parce qu’elles peuvent toucher une relation, un ami, un parent. Toutefois, la perception qu’on peut en avoir lorsqu’un de nos proches est affecté est largement indépendante du poids de la maladie dans la population générale même si elle est bien évidemment liée aux modalités actuelles de prise en charge.
Enquete attractivite-lir leem-aec
Capitaliser sur les résultats de l’Enquête 2008
Attractivité de la France au sein de la Recherche Clinique Internationale conduite par le Leem pour conduire une analyse comparative
entre les données des adhérents du LIR
et celles de l’ensemble des participants de l’Industrie
Consommation de medicaments_dans_5_pays_europeens
Le niveau de consommation de médicaments en France est souvent considéré comme étant l’un des plus importants d’Europe. Cette étude cherche à vérifier la persistance de cette affirmation sur la période 2000-2004 en comparant les niveaux de consommation de 7 classes de médicaments en Allemagne, Espagne, France, Italie et Royaume-Uni. Non seulement la France n’était plus en 2004 le premier consommateur dans les 7 classes étudiées mais on constate un rapprochement aussi bien des niveaux de consommation que des structures de consommation entre les 5 pays.
Prise en-charge-personnes-agees
Quelle prise en charge sanitaire et médico-sociale des personnes âgées, Quelle anticipation des besoins futurs ?
Dp debats femmes-et_sante
une enquête auprès des Françaises pour voir comment elles perçoivent l’avenir du système de santé
Policies for conflicts_of_interest
This document summarizes policies for managing conflicts of interest in health systems from four countries: the United States, United Kingdom, Germany, and Sweden. It defines a conflict of interest and discusses who such policies apply to, including both internal employees and external experts/contractors. It examines the types of interests that should be declared, such as pecuniary and non-pecuniary interests as well as family interests. The document also outlines when and how interests should be declared, either upon appointment, before meetings, or annually. Finally, it notes some of the challenges around setting appropriate limits for interest declarations.
Lir2011 discours vpecresse-
1. The document discusses a speech given by a French Minister to an international pharmaceutical research group about France's efforts to combat infectious diseases through increased medical research funding and public-private partnerships.
2. Over the past 4 years, France has massively increased funding for medical research and provided tax incentives to encourage partnerships between public research laboratories and private companies.
3. Key initiatives include the creation of a research alliance called AVIESAN to better coordinate resources and projects, as well as programs that provide over €1 billion in funding for projects related to biomedical research and technologies.
More from Association LIR (20)
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Proposition+alliance+sur+info+patien+gp +assmed-avril2011
Recently uploaded
Patellar Instability: Diagnosis Management
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
What are the different types of Dental implants.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Ageing, the Elderly, Gerontology and Public Health
Challenges associated with ageing from a public health perspective
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montrealComputer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Cervical Disc Arthroplasty ORSI 2024.pptx
Indication and installation of a mobile cervical disc prosthesis. Benefits of the PRODISC C VIVO mobile disc prosthesis (Centinel Spine)
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
cosmetics and cosmeceuticals
Muskan
mpharm
2nd semester
Guru Gobind Singh college of pharmacy, yamunanagar, haryana
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...ayushrajshrivastava7
Regulatory Affairs
Full hand written notes
M.pharm - 1st year .5 Effective Homeopathic Medicines for Irregular Periods
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Recently uploaded (20)
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
1.0 jean-françois delfraissy intro
- 1. 3rd International Research Meeting June 10th, 2011, Hôtel Marigny Introduction Pr Jean-François Delfraissy Institut de Microbiologie et Maladies Infectieuses (IMMI) Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) CHU Bicetre – Paris XI CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
- 2. Infectious diseases account for 26% of all deaths worldwide Leading cause of mortality in ressources limited countries Two-thirds of worldwide deaths in children <5 years old The Heavy Burden of Infectious Diseases % of deaths 18% 15% 31% 36% Pneumonia Diarrhoea Other infections Non infectious
- 6. IMMI: French Biomedical research Centers Institut Pasteur Paris Pitié Salpétrière Mondor/Bicêtre/Orsay/CEA/Saclay Bichat/St Louis Cochin/Cordeliers BIOPOLE Lyon-Grenoble IRT Lyon/Pasteur Institut Pasteur Lille Bordeaux Strasbourg INFECTIOPOLE Sud Marseille-Montpellier-Nice IHU